Femme et Homme
- | Pays :
- China
- | Organes : -
- | Spécialités : -
Extrait
This study is multi-center randomized phase III one to evaluate the difference in local-control and survival rate between patients receiving concurrent chemoradiotherapy combined Tarceva or not.
Critère d'inclusion
- Esophageal Cancer